Patent ID: 7041649

Claim:
A method of treating a mammal with a condition of the nervous system, the method comprising administering to a mammal an effective amount of a compound selected from the group consisting of a) AcPhe-Aib-Aib-Aib-Xaa 1 -Xaa 2 -Leu-Xaa 3 -Aib-Hyp-Gln-Xaa 4 -Hyp-Aib-Pro-Xaa 5 (SEQ ID NO:9), wherein Xaa 5 is Phe-ol or Phe-al, and Xaa 1 , Xaa 2 , Xaa 3 , and Xaa 4 are as follows: i) Xaa 1 is Aib, Xaa 2 is Gly or Ala, and Xaa 3 and Xaa 4 are Iva; ii) Xaa 1 is Iva, Xaa 2 is Gly, and Xaa 3 and Xaa 4 are Iva; iii) Xaa 1 is Aib, Xaa 2 is Gly, Xaa 3 is Iva, and Xaa 4 is Aib; iv) Xaa 1 is Aib, Xaa 2 is Gly, and Xaa 3 and Xaa 4 are Aib; or v) Xaa 1 is Aib, Xaa 2 is Gly, Xaa 3 is Aib and Xaa 4 is Iva; b) AcPhe-Iva-Gln-Aib-Ile-Thr-Aib-Leu-Aib-Xaa 6 -Gln-Aib-Hyp-Aib-Pro-Phe-Ser (SEQ ID NO:10), wherein Xaa 6 is Hyp or Pro; and c) pharmaceutically acceptable salts of the compounds of a) and b).